EFFECT OF MIRIKIZUMAB ON CLINICAL AND ENDOSCOPIC OUTCOMES AFTER 1 ANTI-TNF FAILURE IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS

Category Primary study
JournalGut
Year 2024
This article has no abstract
Epistemonikos ID: ba4072cb61fb7584d4e8f7703097faee887c5b53
First added on: Feb 19, 2025